The largest database of trusted experimental protocols

Endnote software version x9

Manufactured by Clarivate
Sourced in United States

EndNote X9 is a reference management software that helps users collect, organize, and format citations and bibliographies for academic and professional writing. It provides a centralized database to store, manage, and share references, and supports various citation styles for formatting citations and bibliographies within documents.

Automatically generated - may contain errors

Lab products found in correlation

4 protocols using endnote software version x9

1

Sorafenib Therapy Protocol Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
For ease of administration, references were merged together using Endnote software, version X9 (Clarivate Analytics, Philadelphia, PA, USA). The two researchers (WG and ZT) independently extracted relevant data from eligible studies, including the study's lead author, publication date, country, research methods, data sources, research time, duration of follow-up, study population characteristics (age and sex), exposure, test dose definition, duration of relevant risk assessment (HR, RR, OR and 95% CI) and relevant confounding factors. To account for any combination therapy, the experimental group was defined as treatment with sorafenib and the control group was defined as treatment without sorafenib.
+ Open protocol
+ Expand
2

Streamlining Citation Management

Check if the same lab product or an alternative is used in the 5 most similar protocols
Endnote software version X9 (Clarivate Analytics) was used to manage citations and bibliographies and store articles found and eliminate duplicates.
+ Open protocol
+ Expand
3

Systematic Literature Review Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
All articles were organized using EndNote software version X9 (Clarivate, Philadelphia, Pennsylvania, USA), and data were abstracted into a Microsoft Excel table. Two reviewers independently screened all titles and abstracts to determine articles that could immediately be excluded and articles that should be included in the second stage of review. Results were compared to reconcile any differences between the two reviewers. The first and second reviewers then independently read the full text of potentially eligible articles identified through screening and selected the articles that were candidates for inclusion in the study. Results were compared to reconcile any differences between the two reviewers. A third-party reviewer adjudicated when consensus was not reached between the two reviewers during the first or second stage review. From those studies deemed eligible, data were extracted from articles by one reviewer using the data abstraction tool in Microsoft Excel.
+ Open protocol
+ Expand
4

Gestational Diabetes Mellitus and Arsenic Exposure

Check if the same lab product or an alternative is used in the 5 most similar protocols
A comprehensive search for studies was conducted in the PubMed, Embase, and Scopus databases from inception through September 8, 2023. The search was limited to studies published in English. The search strategy included the keywords “Diabetes, Gestational”, “Diabetes, Pregnancy-Induced”, “Gestational Diabetes”, “Diabetes Mellitus, Gestational”, “Gestational Diabetes Mellitus”, “Arsenic”, and “Arsenic-75”. The MeSH terms and Boolean operators were used to develop a robust search strategy. The detailed search strategies for each database are provided in Supplementary 1. Studies identified through a systematic search were retrieved and managed using EndNote software version X9 (Clarivate Analytics, Philadelphia, USA, 2013). All literature searches were conducted by two independent reviewers.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!